Kutatási jelek – Signal Engine

• Surgical treatment of hepatocellular carcinoma: expert consensus statement — Hepatocellular carcinoma
• Pancreatic cancer — Pancreatic cancer
• Prognostic Impact of RAS and TP53 Mutation Profiles in Metastatic Colorectal Cancer — Colorectal cancer
• Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery — Ewing sarcoma
• Osteosarcoma treatment: state of the art — Osteosarcoma
• Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer — Prostate cancer
• Pancreatic cancer: molecular pathogenesis and new therapeutic targets — Pancreatic cancer
• Antibody-Based Therapeutics in Small Cell Lung Cancer: A Narrative Review — SCLC
• Clinical Trials Register — Hepatocellular carcinoma
• Recurrence after treatment of micropapillary thyroid cancer — Thyroid cancer
• Comparison of radical cystectomy and radical radiotherapy for muscle‑invasive bladder cancer — Bladder cancer
• Prostate Cancer Treatment Protocols: Treatment Protocols — Prostate cancer
• Canadian recommendations for the treatment of glioblastoma multiforme — Diffuse large B-cell lymphoma
• Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial — Renal cell carcinoma
• The evolving biology and treatment of prostate cancer — Prostate cancer
• Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment — Breast cancer
• New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance — Chronic myeloid leukemia
• Breast Cancer Treatment among Older Women in Integrated Health Care Settings — Breast cancer
• Clinical trials for Neuroblastoma — Neuroblastoma
• Targeted Therapy Paradigm Grows in NSCLC, While Overcoming Resistance Represents Next Hurdle — NSCLC